YALE UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1701-10-09

Employees: 10K

Market Cap: -

Website: http://www.yale.edu

Clinical Trials

Using an Artificial Pancreas System in Older Adult Type 1 Diabetes Mellitus Patients

Not Applicable

Terminated

Conditions: Type1 Diabetes Mellitus

Interventions: Device: usual diabetic care
Device: CL/AP system

First Posted Date: 2017-11-27

Last Posted Date: 2022-11-18

Lead Sponsor: Yale University

Target Recruit Count: 7

Registration Number: NCT03353792

Locations: 🇺🇸
Yale New Haven Hospital, New Haven, Connecticut, United States

Feasibility of an Activity Regimen in Patients With Advanced Stage Lung Cancer

Not Applicable

Completed

Conditions: Lung Neoplasm Malignant

Interventions: Behavioral: Prescribed Activity

First Posted Date: 2017-11-24

Last Posted Date: 2024-02-15

Lead Sponsor: Yale University

Target Recruit Count: 40

Registration Number: NCT03352245

Locations: 🇺🇸
Yale University, New Haven, Connecticut, United States

Study of Low Carbohydrate Enteral Nutrition in Patients With Bacterial Septic Shock

Not Applicable

Withdrawn

Conditions: Bacterial Sepsis

Interventions: Dietary Supplement: low-carbohydrate nutrition
Dietary Supplement: Standard enteral nutrition

First Posted Date: 2017-11-17

Last Posted Date: 2021-11-26

Lead Sponsor: Yale University

Registration Number: NCT03343041

Locations: 🇺🇸
Yale New Haven Hospital, New Haven, Connecticut, United States

Psilocybin for the Treatment of Migraine Headache

Phase 1

Completed

Conditions: Migraine Headache

Interventions: Drug: Low Dose Psilocybin
Drug: High Dose Psilocybin
Drug: Placebo

First Posted Date: 2017-11-14

Last Posted Date: 2023-10-12

Lead Sponsor: Yale University

Target Recruit Count: 14

Registration Number: NCT03341689

Locations: 🇺🇸
VA Connecticut Healthcare System, West Haven Campus, West Haven, Connecticut, United States

Metabotropic Glutamate Receptor-5 (mGlur5) Effects on Reward-Related fMRI-BOLD Activation in FHP and FHN

Early Phase 1

Completed

Conditions: Familial Alcoholism Vulnerability

Interventions: Drug: Mavoglurant (AFQ056)
Other: Placebo

First Posted Date: 2017-11-14

Last Posted Date: 2022-01-11

Lead Sponsor: Yale University

Target Recruit Count: 18

Registration Number: NCT03341715

Locations: 🇺🇸
Hartford Hospital, Hartford, Connecticut, United States

Natural History of Wilson Disease

Recruiting

Conditions: Wilson Disease

First Posted Date: 2017-11-07

Last Posted Date: 2025-05-22

Lead Sponsor: Yale University

Target Recruit Count: 300

Registration Number: NCT03334292

Locations: 🇺🇸
Baylor College of Medicine, Houston, Texas, United States
🇺🇸
Yale University, New Haven, Connecticut, United States
🇬🇧
Royal Surrey Country Hospital, Guildford, Surrey, United Kingdom

and more 3 locations

EEG - Guided Anesthetic Care and Postoperative Delirium

Not Applicable

Completed

Conditions: Anesthesia, General
Laparoscopy
Delirium
Electroencephalography
Surgical Procedures, Operative
Emergence Delirium

Interventions: Device: Anesthetic "depth" management

First Posted Date: 2017-11-06

Last Posted Date: 2020-11-09

Lead Sponsor: Yale University

Target Recruit Count: 1560

Registration Number: NCT03330236

Locations: 🇨🇳
Xiangya Hospital, Changsha, Hunan, China

Mavoglurant in Alcohol Drinking

Phase 1

Completed

Conditions: Alcohol Drinking

Interventions: Drug: Placebo
Drug: Mavoglurant

First Posted Date: 2017-10-31

Last Posted Date: 2024-08-06

Lead Sponsor: Yale University

Target Recruit Count: 34

Registration Number: NCT03327792

Locations: 🇺🇸
CMHC, Substance Abuse Center, New Haven, Connecticut, United States

Lifestyle, Exercise, and Nutrition Study Early After Diagnosis

Not Applicable

Active, not recruiting

Conditions: Breast Neoplasms

Interventions: Behavioral: Usual Care
Behavioral: Dietary/Physical Activity intervention

First Posted Date: 2017-10-19

Last Posted Date: 2025-02-03

Lead Sponsor: Yale University

Target Recruit Count: 173

Registration Number: NCT03314688

Locations: 🇺🇸
Yale University, New Haven, Connecticut, United States
🇺🇸
Dana Farber Cancer Center, Boston, Massachusetts, United States

Pilot of Pragmatic SBIRT Study

Not Applicable

Completed

Conditions: Substance Use Disorders
Pain

Interventions: Behavioral: SBIRT-PM

First Posted Date: 2017-10-12

Last Posted Date: 2024-02-15

Lead Sponsor: Yale University

Target Recruit Count: 40

Registration Number: NCT03307967

Locations: 🇺🇸
VA Connecticut Healthcare System (VACHS), West Haven, Connecticut, United States
🇺🇸
Yale University, New Haven, Connecticut, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy